Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study. (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s188. https://doi.org/10.25251/skin.7.supp.188